Latest News

CREST-2: Stenting Benefits Asymptomatic Carotid Stenosis
Written by: Radcliffe Vascular
CREST-2: Stenting Benefits Asymptomatic Carotid Stenosis
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
Written by: Radcliffe Vascular
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
STORM-PE: Thrombectomy Superior for Intermediate-Risk PE
Written by: Radcliffe Cardiology
STORM-PE: Thrombectomy Superior for Intermediate-Risk PE
New Metabolic Target for Thoracic Aortic Aneurysms
Written by: Radcliffe Vascular
New Metabolic Target for Thoracic Aortic Aneurysms
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
Written by: Radcliffe Cardiology
CREST-2: Stenting Benefits in Asymptomatic Carotid Stenosis
ViTAA Medical Secures FDA 510(k) Clearance for AiORTA™ Plan — Marking the First Step in Its Hyper-Precise Aortic Care Platform
Written by: Radcliffe Vascular
ViTAA Medical Secures FDA 510(k) Clearance for AiORTA™ Plan — Marking the First Step in Its Hyper…
Semaglutide Improves PAD Outcomes Regardless of Sex
Written by: Radcliffe CVRM
Semaglutide Improves PAD Outcomes Regardless of Sex
COVID-19 Linked to Vascular Ageing, Especially in Women
Written by: Radcliffe Vascular
COVID-19 Linked to Vascular Ageing, Especially in Women
Retinal Vascular Density Linked to Subclinical Coronary Atherosclerosis
Written by: Radcliffe Cardiology
Retinal Vascular Density Linked to Subclinical Coronary Atherosclerosis
Paclitaxel-Coated Devices Do Not Reduce Amputation Risk in Chronic Limb-Threatening Ischaemia
Written by: Radcliffe Vascular
Paclitaxel-Coated Devices Do Not Reduce Amputation Risk in Chronic Limb-Threatening Ischaemia

External news

Written by: Cardiovascular Business
Cardiologists propose new 'coronary risk zone' approach for redo TAVR planning
Written by: Cardiovascular Business
Cardiac imaging registry expands to include former NBA, NHL players
Written by: Cardiovascular Business
CCTA delivers value, even when treating low-risk patients with no history of CAD
Written by: Cardiovascular Business
MRI scans evaluate heart failure risk—no invasive catheterization required
Written by: Cardiovascular Business
Ultrathin iron bioresorbable scaffold shows promise in first randomized trial
Written by: Cardiac Vascular News
Valcare Medical Announces First U.S. Transseptal AMEND™ Implant in Early Feasibility Study
Written by: Cardiovascular Business
Cardiologist discusses Lp(a), the CVD risk factor responsible for many surprise heart attacks
Written by: Cardiovascular Business
Edwards celebrates double-digit TAVR sales growth in Q4
Written by: Cardiovascular Business
Billionaire donates $50M to advance cardiovascular care at Northwestern
Written by: Cardiovascular Business
New heart catheter for cell therapy delivery 1 step closer to FDA approval